Hosking Partners LLP lifted its stake in shares of Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 52.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 212,720 shares of the financial services provider’s stock after acquiring an additional 73,203 shares during the period. Hosking Partners LLP’s holdings in Trupanion were worth $10,253,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. Quest Partners LLC acquired a new position in shares of Trupanion during the third quarter valued at about $37,000. Wilmington Savings Fund Society FSB acquired a new position in Trupanion during the 3rd quarter worth approximately $54,000. KBC Group NV bought a new position in Trupanion in the fourth quarter worth approximately $75,000. R Squared Ltd acquired a new stake in Trupanion in the fourth quarter valued at approximately $79,000. Finally, GAMMA Investing LLC increased its holdings in shares of Trupanion by 18.5% during the fourth quarter. GAMMA Investing LLC now owns 1,709 shares of the financial services provider’s stock valued at $82,000 after acquiring an additional 267 shares in the last quarter.
Trupanion Stock Performance
Shares of TRUP stock opened at $33.59 on Friday. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The firm has a 50-day moving average of $46.20 and a 200-day moving average of $47.82. Trupanion, Inc. has a one year low of $19.69 and a one year high of $57.90. The company has a market cap of $1.42 billion, a P/E ratio of -146.04, a P/E/G ratio of 6.02 and a beta of 1.60.
Insider Buying and Selling
In other news, CFO Fawwad Qureshi sold 1,373 shares of the firm’s stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total transaction of $46,984.06. Following the completion of the sale, the chief financial officer now directly owns 2,416 shares of the company’s stock, valued at $82,675.52. This trade represents a 36.24 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 5.50% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
Several analysts recently issued reports on the stock. Northland Securities lifted their price target on shares of Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research report on Thursday, October 31st. Stifel Nicolaus reduced their price objective on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a report on Thursday, February 20th. Finally, Piper Sandler lowered their target price on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $46.60.
Read Our Latest Report on TRUP
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Articles
- Five stocks we like better than Trupanion
- How to Calculate Inflation Rate
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- P/E Ratio Calculation: How to Assess Stocks
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Consumer Discretionary Stocks Explained
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.